BCL2L1 and breast carcinoma: In luminal breast cancer cells, we have shown that CAFs conditioned-media-induced apoptotic resistance to BCL-2/BCL-xL inhibitors could be completely reversed with a BH-3 mimetic targeting MCL-1 (A1210477).